Biom'up: Athryium-backed Biom'up adds two to C-suite
Biom'up, a developer of hemostatic products, has named Stéphanie Boileau-Canu as chief financial officer and Emmanuel Zylber as chief scientific officer.
Read full article »
Biom’Up designs, manufactures and markets hemostatic products for spine, cardiothoracic and orthopedic surgical procedures.
Read more